Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $5.14 USD
Change Today +0.08 / 1.58%
Volume 50.5K
CCM On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

concord medical - spon adr (CCM) Snapshot

Open
$4.98
Previous Close
$5.06
Day High
$5.25
Day Low
$4.98
52 Week High
09/8/14 - $8.25
52 Week Low
08/25/15 - $4.51
Market Cap
231.0M
Average Volume 10 Days
49.2K
EPS TTM
$0.39
Shares Outstanding
44.9M
EX-Date
08/5/14
P/E TM
13.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for CONCORD MEDICAL - SPON ADR (CCM)

concord medical - spon adr (CCM) Related Bloomberg News

View More Bloomberg News

concord medical - spon adr (CCM) Related Businessweek News

View More BusinessWeek News

concord medical - spon adr (CCM) Details

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy, and diagnostic imaging services. The company also offers other treatments and diagnostic services through the use of medical equipment comprising electroencephalography for the diagnosis of epilepsy; thermotherapy for pain relief after radiotherapy and chemotherapy; ultrasound therapy for the treatment of cancer; stereotactic radiofrequency ablation for the treatment of Parkinson’s disease; and refraction and tonometry for the diagnosis of ophthalmic conditions. In addition, it provides clinical support services, such as developing treatment protocols for doctors; and organizing joint diagnosis between doctors in its network and clinical research. Further, the company offers radiotherapy and diagnostic equipment leasing and management services to hospitals, as well as sells medical equipment. Additionally, it also engages in establishing the Beijing Proton Medical Center that would offer radiotherapy treatment options to cancer patients; and Guangzhou Concord Medical Cancer Hospital, a 400-bed specialty hospital for cancer diagnosis and treatment, as well as other specialty cancer hospitals that would offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2014, the company operated a network of 139 centers based in 80 hospitals, spanning 56 cities across 25 provinces and administrative regions in China. Concord Medical Services Holdings Limited was incorporated in 2007 and is headquartered in Beijing, the People’s Republic of China.

601 Employees
Last Reported Date: 04/27/15
Founded in 2007

concord medical - spon adr (CCM) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

concord medical - spon adr (CCM) Key Developments

Concord Medical Services Holdings Limited Reports Consolidated Unaudited Earnings Results for the First Quarter Ended June 30, 2015

Concord Medical Services Holdings Limited reported consolidated unaudited earnings results for the first quarter ended June 30, 2015. For the quarter, the company reported total net revenues were RMB 174,549,000 compared with RMB 160,808,000 for the same period last year. Operating income was RMB 19,705,000 compared with RMB 52,394,000 for the same period last year. Income from continuing operations before income tax was RMB 51,285,000 compared with RMB 45,905,000 for the same period last year. Net income from continuing operations was RMB 36,444,000 or RMB 0.81 diluted per share compared with RMB 30,752,000 or RMB 0.60 diluted per share for the same period last year. Net income attributable to ordinary shareholders was RMB 36,534,000 or RMB 0.81 diluted per share compared with RMB 34,999,000 or RMB 0.78 diluted per share for the same period last year. Non-GAAP operating income was RMB 21,871,000 compare with RMB 53,380,000 for the same period last year. Non-GAAP net income was RMB 38,611,000 or RMB 0.86 diluted per share compared with RMB 44,021,000 or RMB 0.89 diluted per share for the same period last year. Adjusted EBITDA was RMB 66,007,000 compared with RMB 92,391,000 for the same period last year. The increase in net revenue from the network business was primarily attributable to improvement in product mix, especially increased contribution from PET-CT and Cyber Knife centers in the network. Capital expenditures of the network business were RMB 26.9 million ($4.3 million) in the second quarter of 2015 compared with RMB 2.5 million in the second quarter of 2014.

Concord Medical Services Holdings Limited to Report Q2, 2015 Results on Aug 17, 2015

Concord Medical Services Holdings Limited announced that they will report Q2, 2015 results at 5:00 PM, China Standard Time on Aug 17, 2015

Concord Medical Services Holdings Limited, Q2 2015 Earnings Call, Aug 18, 2015

Concord Medical Services Holdings Limited, Q2 2015 Earnings Call, Aug 18, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CCM:US $5.14 USD +0.08

CCM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China Wah Yan Healthcare Ltd $0.14 HKD +0.001
View Industry Companies
 

Industry Analysis

CCM

Industry Average

Valuation CCM Industry Range
Price/Earnings 11.5x
Price/Sales 0.9x
Price/Book 0.3x
Price/Cash Flow 11.2x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CONCORD MEDICAL - SPON ADR, please visit www.concordmedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.